Epigenica is proud to have become one of five Swedish start-ups selected to accelerate on the French Precision health market. Through EIT Health Scandinavia and the Swedish-French Accelerator, Epigenica will receive tailor made support during 12 months by EIT Health experts and the French partner network to access the French ecosystem, develop new collaborations and accelerate their solutions on the French market.